In addition, it could lead to hyperactivation of S6K-1, 4EBP1 and eukaryotic translation initiation factor 4E (eIF4E), as well as cancer growth through the activation of lipid and protein biosynthesis. The gene discussed is RPS6KB1; the disease is cancer.